Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00589589 · ClinicalTrials.gov registry record · Phase 1

Computer Decision Support to Achieve Glycemic Control in the ICU

A Phase 1 study, sponsored by United States Army Institute of Surgical Research.

Completed
Registry status
Phase 1
Development phase
24
Enrollment target

NCT00589589: Completed Phase 1 study, sponsored by United States Army Institute of Surgical Research.

NCT00589589 is a Phase 1 study that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00589589, a Phase 1 study, has completed, sponsored by United States Army Institute of Surgical Research.

COMPLETED
Registry status
Phase 1
Development phase
24 participants
Enrollment target

Study Summary

This study is intended to fill the knowledge gap regarding the burn population with research that achieves scientific merit. we will determine the effectiveness of the computer decision support system (CDSS) to facilitate glucose management in the critically ill burn patient. The EndoTool™ computer decision support system will achieve glycemic control (defined as 80-110 mg/dL) in a shorter time, reduce glycemic excursion outside of target range, and reduce incidence of hypoglycemia (blood glucose less than 50 mg/dL) in the critically ill burn patient compared to the standard of care USAISR insulin titration protocol (Appendix A).

Interventions

  • DEVICE Endo Tool

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2008-01
Est. Completion 2011-01
Phase Phase 1

What the finished NCT00589589 record still lists

NCT00589589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).

The record links to 0 conditions, and to 1 intervention - of which Endo Tool is the first listed.

NCT00589589 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00589589 about?

NCT00589589 is a clinical study titled "Computer Decision Support to Achieve Glycemic Control in the ICU". This study is intended to fill the knowledge gap regarding the burn population with research that achieves scientific merit. we will determine the effectiveness of the computer decision support system (CDSS) to facilitate glucose management in the critically ill burn patient. The EndoTool™ computer...

What is the current status of trial NCT00589589?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-01. Estimated completion is 2011-01.

What interventions are being tested in trial NCT00589589?

The interventions under investigation include: Endo Tool (DEVICE).

Who is sponsoring clinical trial NCT00589589?

This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00589589's enrollment target sits among peer trials

24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00589589, the US trial registry maintained by the National Library of Medicine. NCT00589589 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.